Skip to main content
Erschienen in: International Urogynecology Journal 11/2008

01.11.2008 | Original Article

Anticholinergic drugs, bladder retraining and their combination for urge urinary incontinence: a pilot randomised trial

verfasst von: Mel Lauti, Peter Herbison, Jean Hay-Smith, Gaye Ellis, Don Wilson

Erschienen in: International Urogynecology Journal | Ausgabe 11/2008

Einloggen, um Zugang zu erhalten

Abstract

Bladder retraining and anticholinergic drugs in women with urge urinary incontinence need to be compared. Women with urge urinary incontinence were recruited by advertisements, from primary care and from a urogynaecology clinic. Women were randomised using a web page to bladder retraining, anticholinergic drugs or both and followed up at 3 and 12 months. No blinding was attempted. The primary outcomes were the trial process and the Overactive Bladder Questionnaire (OAB-q) quality-of-life measure. Recruitment was much slower than anticipated. There were no differences in the OAB-q at 12 months (87.9 SD 11.6 bladder retraining, 81.6 SD 19.3 drug therapy and 88.9 SD 9.9 combination) but dry mouth was more common in those taking drugs. It is feasible to run a pragmatic randomised trial with 12-month follow-up for women with urinary urge incontinence. This will require about 500 participants per arm.
Literatur
1.
Zurück zum Zitat Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167–178PubMedCrossRef Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167–178PubMedCrossRef
2.
Zurück zum Zitat Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ (2001) How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU International 87:760–766PubMedCrossRef Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ (2001) How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU International 87:760–766PubMedCrossRef
3.
Zurück zum Zitat Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327–336PubMed Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327–336PubMed
4.
Zurück zum Zitat Liberman JN, Hunt TL, Stewart WF, Wein A, Zhou Z, Herzog AR et al (2001) Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey. Urology 57:1044–1050PubMedCrossRef Liberman JN, Hunt TL, Stewart WF, Wein A, Zhou Z, Herzog AR et al (2001) Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey. Urology 57:1044–1050PubMedCrossRef
5.
Zurück zum Zitat van der Vaart CH, de Leeuw JR, Roovers JP, Heintz AP (2002) The effect of urinary incontinence and overactive bladder symptoms on quality of life in young women. BJU Int 90:544–549PubMedCrossRef van der Vaart CH, de Leeuw JR, Roovers JP, Heintz AP (2002) The effect of urinary incontinence and overactive bladder symptoms on quality of life in young women. BJU Int 90:544–549PubMedCrossRef
6.
Zurück zum Zitat Dmochowski RR, Newman DK (2007) Impact of overactive bladder on women in the United States: results of a national survey. Curr Med Res Opin 23:65–76PubMedCrossRef Dmochowski RR, Newman DK (2007) Impact of overactive bladder on women in the United States: results of a national survey. Curr Med Res Opin 23:65–76PubMedCrossRef
7.
Zurück zum Zitat Grimby A, Milsom I, Molander U, Wiklund I, Ekelund P (1993) The influence of urinary incontinence on the quality of life of elderly women. Age Ageing 22:82–89PubMedCrossRef Grimby A, Milsom I, Molander U, Wiklund I, Ekelund P (1993) The influence of urinary incontinence on the quality of life of elderly women. Age Ageing 22:82–89PubMedCrossRef
8.
Zurück zum Zitat Lowenstein L, Brubaker L, Kenton K, Kramer H, Shott S, FitzGerald MP (2007) Prevalence and impact of nocturia in a urogynecologic population. Int Urogynecol J 18:1049–1052CrossRef Lowenstein L, Brubaker L, Kenton K, Kramer H, Shott S, FitzGerald MP (2007) Prevalence and impact of nocturia in a urogynecologic population. Int Urogynecol J 18:1049–1052CrossRef
9.
Zurück zum Zitat Coyne KS, Margolis MK, Jumadilova Z, Bavendam T, Mueller E, Rogers R (2007) Overactive bladder and women’s sexual health: what is the impact? J Sexual Med 4:656–666CrossRef Coyne KS, Margolis MK, Jumadilova Z, Bavendam T, Mueller E, Rogers R (2007) Overactive bladder and women’s sexual health: what is the impact? J Sexual Med 4:656–666CrossRef
10.
Zurück zum Zitat Abrams P, Cardozo L, Khoury S, Wein A (eds) (2005) In: Incontinence. vol. 2. Health Publication Ltd., Plymouth Abrams P, Cardozo L, Khoury S, Wein A (eds) (2005) In: Incontinence. vol. 2. Health Publication Ltd., Plymouth
11.
Zurück zum Zitat Wallace SA, Roe B, Williams K, Palmer M (2004) Bladder training for urinary incontinence in adults. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD001308. doi:10.1002/14651858.CD001308.pub2 Wallace SA, Roe B, Williams K, Palmer M (2004) Bladder training for urinary incontinence in adults. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD001308. doi:10.1002/14651858.CD001308.pub2
12.
Zurück zum Zitat Nabi G, Cody JD, Ellis G, Herbison P, Hay-Smith J (2006) Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD003781. doi:10.1002/14651858.CD003781.pub2 Nabi G, Cody JD, Ellis G, Herbison P, Hay-Smith J (2006) Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD003781. doi:10.1002/14651858.CD003781.pub2
13.
Zurück zum Zitat Herbison P, Hay-Smith J, Ellis G, Moore K (2003) Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder syndrome: systematic review. BMJ 326:841–844PubMedCrossRef Herbison P, Hay-Smith J, Ellis G, Moore K (2003) Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder syndrome: systematic review. BMJ 326:841–844PubMedCrossRef
14.
Zurück zum Zitat Song C, Park JT, Heo KO, Lee KS, Choo MS (2006) Effects of bladder training and/or tolterodine in female patients with overactive bladder syndrome: a prospective, randomized study. J Korean Med Sci 21:1060–1063PubMedCrossRef Song C, Park JT, Heo KO, Lee KS, Choo MS (2006) Effects of bladder training and/or tolterodine in female patients with overactive bladder syndrome: a prospective, randomized study. J Korean Med Sci 21:1060–1063PubMedCrossRef
15.
Zurück zum Zitat Colombo M, Zanetta G, Scalambrino S, Milani R (1995) Oxybutynin and bladder training in the management of female urinary urge incontinence: a randomized study. Int Urogynecol J 6:63–67CrossRef Colombo M, Zanetta G, Scalambrino S, Milani R (1995) Oxybutynin and bladder training in the management of female urinary urge incontinence: a randomized study. Int Urogynecol J 6:63–67CrossRef
16.
Zurück zum Zitat Ghei M, Miller R, Malone-Lee J (2006) Case series data to encourage randomized trials of bladder retraining compared to antimuscarinic agents. J Urol 175:1411–1415PubMedCrossRef Ghei M, Miller R, Malone-Lee J (2006) Case series data to encourage randomized trials of bladder retraining compared to antimuscarinic agents. J Urol 175:1411–1415PubMedCrossRef
17.
Zurück zum Zitat Roland M, Torgerson DJ (1998) Understanding controlled trials. What are pragmatic trials? BMJ 316:285PubMed Roland M, Torgerson DJ (1998) Understanding controlled trials. What are pragmatic trials? BMJ 316:285PubMed
18.
Zurück zum Zitat Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J et al (2002) Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 11:563–574PubMedCrossRef Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J et al (2002) Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 11:563–574PubMedCrossRef
19.
Zurück zum Zitat Karantanis E, Fynes M, Moore KH, Stanton SL (2004) Comparison of the ICIQ-SF and 24-hour pad tests with other measures for evaluating the severity of urodynamic stress incontinence. Int Urogynecol J 15:111–116CrossRef Karantanis E, Fynes M, Moore KH, Stanton SL (2004) Comparison of the ICIQ-SF and 24-hour pad tests with other measures for evaluating the severity of urodynamic stress incontinence. Int Urogynecol J 15:111–116CrossRef
20.
Zurück zum Zitat Coyne KS, Matza LS, Thompson CL, Kopp ZS, Khullar V (2006) Determining the importance of change in the overactive bladder questionnaire. J Urol 176:627–632PubMedCrossRef Coyne KS, Matza LS, Thompson CL, Kopp ZS, Khullar V (2006) Determining the importance of change in the overactive bladder questionnaire. J Urol 176:627–632PubMedCrossRef
21.
Zurück zum Zitat Rothwell PM (2005) Treating individuals 1. External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet 365:82–93PubMedCrossRef Rothwell PM (2005) Treating individuals 1. External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet 365:82–93PubMedCrossRef
Metadaten
Titel
Anticholinergic drugs, bladder retraining and their combination for urge urinary incontinence: a pilot randomised trial
verfasst von
Mel Lauti
Peter Herbison
Jean Hay-Smith
Gaye Ellis
Don Wilson
Publikationsdatum
01.11.2008
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 11/2008
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-008-0686-8

Weitere Artikel der Ausgabe 11/2008

International Urogynecology Journal 11/2008 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.